Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-30 @ 2:45 AM
Study NCT ID:
NCT04121403
Status:
COMPLETED
Last Update Posted:
2024-12-16
First Post:
2019-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
Sponsor:
Oslo University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-23
First Submit QC Date:
None
Study First Post Date:
2019-10-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-11
Last Update Post Date:
2024-12-16
Last Update Post Date Type:
ACTUAL